Eastover Investment Advisors LLC Abb Vie Inc. Transaction History
Eastover Investment Advisors LLC
- $214 Million
- Q4 2024
A detailed history of Eastover Investment Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Eastover Investment Advisors LLC holds 37,375 shares of ABBV stock, worth $6.45 Million. This represents 3.11% of its overall portfolio holdings.
Number of Shares
37,375
Previous 38,057
1.79%
Holding current value
$6.45 Million
Previous $7.52 Million
11.63%
% of portfolio
3.11%
Previous 3.52%
Shares
20 transactions
Others Institutions Holding ABBV
# of Institutions
3,865Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$29.6 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.5 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13.6 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$9.03 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.68 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $305B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...